SIRT1 and colorectal carcinoma: Therefore, CRC cells were sown on cover-glasses, integrated into a 3D TME, and processed as TME control (without resveratrol) or treated with resveratrol (5, 10, 20, or 40μM) immunolabelled with anti-Sirt-1 antibody and evaluated via immunofluorescence microscopy.